FDA Highlights by Bruce Sylvester – Researchers report that finasteride appears to reduce alcohol consumption in some men. The results were published online on June 13, 2013 by Alcoholism:… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.
by Bruce Sylvester – European Organisation for the Research and Treatment of Cancer (EORTC) researchers from the AMAROS (After Mapping of the Axilla: Radiotherapy Or Surgery?) trial reported… read more.
by Bruce Sylvester – More than half of patients with metastatic melanoma treated with the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab have achieved durable tumor… read more.
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.
by Bruce Sylvester – Nine thousand clinicians gathered at the 2013 annual meeting of the European Association for the Study of the Liver/International Liver Congress in Amsterdam on… read more.
by Bruce Sylvester – Long-term use of opioids is linked to an increased higher risk of erectile dysfunction (ED), researchers reported on May 15, 2013 in the journal… read more.
FDA Highlights by Bruce Sylvester – Patients with an elevated cardiac risk treated with beta-blockers on the day of or day following non-cardiac, non-vascular surgery have achieved significantly… read more.
FDA Highlights by Bruce Sylvester – Researchers from the Massachusetts Eye and Ear, Harvard Medical School, and Brigham and Women’s hospital in Boston, Massachusetts report that topical anakinra,… read more.
FDA Highlights by Bruce Sylvester – Patients suffering chemotherapy-induced peripheral neuropathy treated with the anti-depressant duloxetine for 5 weeks achieved a greater reduction in pain compared with patients… read more.
by Bruce Sylvester – taken from the BMJ – Researchers have reported a significant decline in the proportion of young women diagnosed with genital warts in Australia following… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
